(Q46416690)

English

Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: a placebo-controlled, double-blind 31P-MRS crossover study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15804248

Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: a placebo-controlled, double-blind 31P-MRS crossover study (English)

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15804248

mitochondrial DNA

0 references

1 reference

based on heuristic

inferred from title

author name string

C Kornblum

1

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15804248

R Schröder

2

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15804248

K Müller

3

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15804248

M Vorgerd

4

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15804248

J Eggers

5

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15804248

M Bogdanow

6

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15804248

A Papassotiropoulos

7

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15804248

K Fabian

8

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15804248

T Klockgether

9

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15804248

J Zange

10

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15804248

publication date

1 April 2005

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15804248

European Journal of Neurology

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15804248

12

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15804248

4

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15804248

300-309

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15804248

Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2004.00970.X

21 January 2018

Creatine supplementation enhances isometric strength and body composition improvements following strength exercise training in older adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2004.00970.X

21 January 2018

Epidemiology and treatment of mitochondrial disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2004.00970.X

21 January 2018

Treatment of mitochondrial cytopathies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2004.00970.X

21 January 2018

Creatine supplementation in health and disease. Effects of chronic creatine ingestion in vivo: down-regulation of the expression of creatine transporter isoforms in skeletal muscle.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2004.00970.X

21 January 2018

Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2004.00970.X

21 January 2018

Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2004.00970.X

21 January 2018

A placebo-controlled crossover trial of creatine in mitochondrial diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2004.00970.X

21 January 2018

Effectiveness of creatine monohydrate in mitochondrial encephalomyopathies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2004.00970.X

21 January 2018

Beneficial effects of creatine supplementation in dystrophic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2004.00970.X

21 January 2018

Creatine supplementation reduces skeletal muscle degeneration and enhances mitochondrial function in mdx mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2004.00970.X

21 January 2018

Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2004.00970.X

21 January 2018

Creatine monohydrate increases strength in patients with neuromuscular disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2004.00970.X

21 January 2018

Creatine transporter and mitochondrial creatine kinase protein content in myopathies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2004.00970.X

21 January 2018

Creatine monohydrate supplementation does not increase muscle strength, lean body mass, or muscle phosphocreatine in patients with myotonic dystrophy type 1.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2004.00970.X

21 January 2018

Effect of high-dose creatine therapy on symptoms of exercise intolerance in McArdle disease: double-blind, placebo-controlled crossover study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2004.00970.X

21 January 2018

Creatine monohydrate in myotonic dystrophy: a double-blind, placebo-controlled clinical study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2004.00970.X

21 January 2018

Effect of creatine supplementation on phosphocreatine resynthesis, inorganic phosphate accumulation and pH during intermittent maximal exercise

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2004.00970.X

21 January 2018

Creatine supplementation results in elevated phosphocreatine/adenosine triphosphate (ATP) ratios in the calf muscle of athletes but not in patients with myopathies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2004.00970.X

21 January 2018

Mitochondrial impairment of human muscle in Friedreich ataxia in vivo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2004.00970.X

21 January 2018

31P NMR examination of two patients with NADH-CoQ reductase deficiency

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2004.00970.X

21 January 2018

Identifiers

10.1111/J.1468-1331.2004.00970.X

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15804248

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15804248

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46416690&oldid=2110409941"